Marcus A. Conant
Corporate Officer/Principal bij The University of California, San Francisco
Profiel
Marcus A.
Conant is Chief Medical Officer of Presidio Pharmaceuticals, Inc., a Clinical Professor at the University of California, San Francisco, and Chairman of the Conant Foundation.
He was a Director of Enzo Biochem, Inc. Dr. Conant has 25 years of experience in treating HIV/AIDS patients.
He received a BS degree and an MD from Duke University.
Actieve functies van Marcus A. Conant
Bedrijven | Functie | Begin |
---|---|---|
The University of California, San Francisco | Corporate Officer/Principal | - |
Eerdere bekende functies van Marcus A. Conant
Bedrijven | Functie | Einde |
---|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | - |
ENZO BIOCHEM, INC. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ENZO BIOCHEM, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |